Skip to content

Revenue at other companies

Henry Schein logo
Henry ScheinHSIC
$3.37B+6.3%
CSX logo
CSXCSX
$3.48B+1.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$246.09M+87.0%
SBA Communications logo
SBA CommunicationsSBAC
$47.29M-1.6%
Loar Holdings logo
Loar HoldingsLOAR
$9.7M+48.1%
Armstrong World Industries logo
Armstrong World IndustriesAWI
$382.9M+12.8%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's revenue?
HealthEquity (HQY) reported revenue of $354.64M in Q1 2026.
How has HealthEquity's revenue changed year-over-year?
HealthEquity's revenue increased by 7.2% year-over-year, from $330.84M to $354.64M.
What is the long-term trend for HealthEquity's revenue?
Over 4 years (2022 to 2026), HealthEquity's revenue has grown at a 14.8% compound annual growth rate (CAGR), from $756.56M to $1.31B.